The pharmaceutical industry's pursuit of novel therapeutics hinges on a consistent and reliable supply of high-quality intermediates. These chemical building blocks are the foundation upon which complex Active Pharmaceutical Ingredients (APIs) are constructed. Among the array of essential intermediates, 2-Bromo-1-(3,5-difluorophenyl)ethanone (CAS 220607-75-0) has emerged as a compound of significant interest due to its utility in synthesizing fluorinated drug candidates.
2-Bromo-1-(3,5-difluorophenyl)ethanone, a white to off-white solid with a high purity of ≥98.0%, offers a valuable combination of reactivity and specific structural features. The presence of the 3,5-difluorophenyl group can impart desirable pharmacokinetic properties to drug molecules, such as improved bioavailability and metabolic stability. The reactive bromoacetyl functionality allows for facile incorporation into diverse molecular architectures through established synthetic routes. For pharmaceutical companies, securing a dependable source for this intermediate is not just about obtaining a chemical; it's about ensuring the continuity and efficiency of their drug development pipelines.
When procuring pharmaceutical intermediates, especially those with specialized structures like 2-Bromo-1-(3,5-difluorophenyl)ethanone, partnering with a reputable manufacturer is paramount. Buyers should look for suppliers who demonstrate stringent quality control, possess robust manufacturing capabilities, and offer transparency in their processes. Manufacturers based in China are often key suppliers, offering competitive pricing and the capacity to meet large-scale demands. It is advisable for procurement managers to perform thorough due diligence, including requesting samples for rigorous testing and verifying the supplier's track record in the pharmaceutical chemical sector.
A stable supply chain for critical pharmaceutical intermediates like 2-Bromo-1-(3,5-difluorophenyl)ethanone is indispensable for reducing risks and accelerating the path from laboratory research to market-ready medications. By prioritizing quality, reliability, and strong supplier relationships, the pharmaceutical sector can continue to innovate and deliver life-changing treatments.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.